secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001213900-25-053588
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex cancels all Series A Warrants, eliminating 347.2M shares of potential dilution
--------------------------------------------------------------------------------

- Cancelled remaining 172M Series A Warrants for $12.2M via ATM facility; combined with earlier tranche removes 347.2M shares.
- CEO Joel Latham says cancellation eliminates significant dilution ahead of Phase 2 RePOSA topline data for IHL-42X in July 2025.
- IHL-42X is a potential first-in-class oral therapy for obstructive sleep apnea, a condition with no FDA-approved drug.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025053588/0001213900-25-053588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025053588/ea0245396-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-053588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer